The use of dendritic cells in cancer therapy
- 1 June 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (6), 343-353
- https://doi.org/10.1016/s1470-2045(00)00389-2
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Idiotypic protein-pulsed dendritic cell vaccination in multiple myelomaInternational Journal of Cancer, 1999
- Analysis of a Chronic Myelogenous Leukemia Patient Vaccinated with Leukemic Dendritic Cells Following Autologous Peripheral Blood Stem Cell TransplantationJapanese Journal of Cancer Research, 1999
- Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cellsJCI Insight, 1999
- Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3The Journal of Experimental Medicine, 1999
- Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNANature Biotechnology, 1998
- Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cellsHuman Immunology, 1997
- Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3International Journal of Cancer, 1995
- Proliferating dendritic cell progenitors in human blood.The Journal of Experimental Medicine, 1994
- Tolerance, Danger, and the Extended FamilyAnnual Review of Immunology, 1994
- Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.The Journal of Experimental Medicine, 1990